In progress
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Work Plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
First and second generation anticoagulant rodenticides Timeframe calculation pursuant to Regulation 78B of the Agricultural and Veterinary Chemicals Code Regulations 1995A + B + 2E + 3C + J + D + X = 42 months
A = 13 months (Environment – level 1)
B = 13 months (Health – level 1)
C = 3 months (Finalisation – type 1)
D = 4 months
E = 0 months
J = 3 months (consultation with jurisdictional coordinator)
X = 0 months (in any other case)
1. Nomination
Completed
1. Nomination
Phase status: Completed
Anticoagulant rodenticides; warfarin, coumatetralyl, diphacinone, brodifacoum, bromadiolone, difenacoum, difethialone, and flocoumafen, were nominated for review and prioritised for consideration on the basis of public health, worker safety and environmental safety.
2. Prioritisation
Completed
2. Prioritisation
Phase status: Completed
3. Scoping and work plan
Completed
3. Scoping and work plan
Phase status: Completed
4. Notice of reconsideration
Completed
4. Notice of reconsideration
Phase status: Completed
Notice of the reconsideration of anticoagulant rodenticides under section 32(1) of the Agvet Code was sent to affected holders of product registrations and label approvals, and active constituent approvals on 2 November 2021. Notice of the reconsideration was also published in the APVMA Gazette of 2 November 2021 and included details on how to submit information to be considered as part of the reconsideration.
The period for submission of information to be assessed under this reconsideration closed on 2 February 2022.
An s 33 notice was sent to a holder on 28 November 2022 to request additional data.
5. Assessment
Completed
5. Assessment
Phase status: Completed
The statutory period for assessments to be completed is 26 months.
The component risk assessments have been completed, and the proposed regulatory decisions have been drafted.
6. Proposed regulatory decision
Completed
6. Proposed regulatory decision
Phase status: Completed
The APVMA published the proposed regulatory decision (PRD) for the anticoagulant rodenticides reconsideration in an APVMA Special Gazette on 16 December 2025.
7. Consultation
In Progress
7. Consultation
Phase status: In Progress
The legislated timeframe for consultation following publication of the proposed regulatory decision is 3 months.
A public consultation (from 16 December 2025 through to 16 March 2026) will be held for the proposed regulatory decision.
8. Final regulatory decision
Forecasted
8. Final regulatory decision
Phase status: Forecasted
The final regulatory decision will be published following the end of the public consultation period on the proposed regulatory decision, and consideration of submissions received.
The APVMA will provide an estimated date for the final decision after the public consultation period has ended depending on the number and complexity of submissions received.
9. Implementation
Forecasted
9. Implementation
Phase status: Forecasted
The implementation period will begin on the date the final regulatory decision is made.
Publication Archive
| Type | Title | Publication date |
|---|---|---|
| Data list | Anticoagulant rodenticides data list | 16 December 2025 |
| Public consultation | Anticoagulant rodenticides proposed regulatory decision | 16 December 2025 |
| Report | Anticoagulant rodenticides Review Technical Report | 16 December 2025 |
| Gazette | Special Gazette, 16 December 2025 | 16 December 2025 |
| Public consultation | Submissions received in response to 2020 public consultation | 2 November 2021 |
| Work plan | Rodenticides reconsideration work plan | 2 November 2021 |
| Gazette | Notice of reconsideration | 2 November 2021 |